American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

SYNLOGIC, INC. (SYBX)

$1.05 +5.00% OTC: SYBX · 15-min delayed

WINCHESTER, Massachusetts
Public · OTC: SYBX

Visit website Follow

$0Revenue · FY2025

-$1.0MNet income

SYBXOTC

About SYNLOGIC, INC.

SYNLOGIC INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: SYBX
Headquarters: WINCHESTER, Massachusetts
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: SYBX OTC
SEC CIK: 1527599
EIN: 261824804
SIC: 2834 Pharmaceutical Preparations

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Synlogic, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/synlogic-inc/"><img src="https://americancompanies.com/badge/synlogic-inc.svg" alt="Synlogic, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow SYNLOGIC, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $0
Net income: -$1.0M
Total assets: $15.4M

Source: SEC EDGAR · updated Jun 7, 2026

OTC: SYBX

$1.05 +5.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.56 $1.83

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Synlogic, Inc. (SYBX) Stock Price

Reported a net loss of $1.0M in FY2025.
Trading 43% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review SYNLOGIC, INC..

Write a review

Newsroom

News about SYNLOGIC, INC.

Halper Sadeh LLC is Investigating Whether BWMN, SUNS, DV, SYBX are Obtaining Fair Deals for their Shareholders GlobeNewswire Inc. · 2026-08-29 · negative Halper Sadeh LLC is Investigating Whether VREX, BWMN, NATH, SYBX are Obtaining Fair Deals for their Shareholders GlobeNewswire Inc. · 2026-08-28 · negative Synlogic Reports First Quarter 2024 Financial Results GlobeNewswire Inc. · 2024-05-14 Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates Zacks Investment Research · 2024-03-19 Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue Estimates Zacks Investment Research · 2024-03-13 Synlogic Adopts Limited Duration Stockholders Rights Plan GlobeNewswire Inc. · 2024-02-20

News & sentiment via Polygon.io

FAQ

Synlogic, Inc.: frequently asked questions

Is Synlogic, Inc. an American company?

Synlogic, Inc. is a US-based company headquartered in Winchester, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Synlogic, Inc. headquartered?

Synlogic, Inc. is headquartered in Winchester, Massachusetts, United States.

Is Synlogic, Inc. publicly traded?

Yes — Synlogic, Inc. is a publicly traded company. Its stock trades under the ticker symbol SYBX on the OTC.

What does Synlogic, Inc. do?

Synlogic, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore